Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -142,375 | -114,705 | -85,908 | -47,647 | -162,667 |
| Depreciation Amortization | -3,331 | -2,765 | -1,916 | -916 | 4,104 |
| Accounts receivable | 7,522 | 7,580 | 6,844 | 6,323 | -2,635 |
| Accounts payable and accrued liabilities | -4,977 | -3,187 | -2,256 | 4,840 | 3,207 |
| Other Working Capital | -18,376 | -16,819 | -12,337 | -2,849 | -20,712 |
| Other Operating Activity | 29,335 | 20,657 | 13,498 | -1,578 | 34,264 |
| Operating Cash Flow | $-132,202 | $-109,239 | $-82,075 | $-41,827 | $-144,439 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 115,539 | 88,159 | 61,000 | 36,311 | 16,180 |
| PPE Investments | -1,252 | -1,064 | -774 | -670 | -1,858 |
| Investing Cash Flow | $114,287 | $87,095 | $60,226 | $35,641 | $14,322 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,775 | 1,664 | 1,664 | 279 | 4,787 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 49,446 |
| Financing Cash Flow | $1,775 | $1,664 | $1,664 | $279 | $54,233 |
| Beginning Cash Position | 77,410 | 77,410 | 77,410 | 77,410 | 153,294 |
| End Cash Position | 61,270 | 56,930 | 57,225 | 71,503 | 77,410 |
| Net Cash Flow | $-16,140 | $-20,480 | $-20,185 | $-5,907 | $-75,884 |
| Free Cash Flow | |||||
| Operating Cash Flow | -132,202 | -109,239 | -82,075 | -41,827 | -144,439 |
| Capital Expenditure | -1,252 | -1,064 | -774 | -670 | -1,858 |
| Free Cash Flow | -133,454 | -110,303 | -82,849 | -42,497 | -146,297 |